Related Experiment Video
Updated: Jun 24, 2026
10:28
Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
Published on: May 24, 2018
[Metabolically obese with normal weight individuals: an intriguing phenotype]
1Service de Diabétologie, Nutrition et Maladies métaboliques et Unité de Pharmacologie clinique, Département de Medecine, CHU de Liege.
Revue Medicale De Liege
|March 26, 2009
Summary
Many non-obese individuals have metabolic syndrome, increasing cardiovascular risk. This phenotype is often missed due to normal body weight, highlighting the need for better detection and management strategies.
Area of Science:
- Metabolic health
- Cardiovascular disease risk factors
- Obesity research
Background:
- Abdominal obesity is a primary driver of metabolic syndrome.
- Non-obese individuals can exhibit metabolic abnormalities, posing significant cardiovascular risks.
- Normal body weight can mask underlying metabolic dysfunction, leading to underdiagnosis.
Purpose of the Study:
- To elucidate the etiopathogenesis and pathophysiology of metabolically abnormal normal-weight individuals.
- To evaluate the clinical implications and cardiovascular risks associated with this phenotype.
- To outline therapeutic strategies for managing metabolically abnormal normal-weight individuals.
Main Methods:
- Review of existing literature on metabolic syndrome and normal-weight individuals with metabolic dysfunction.
- Analysis of etiological factors contributing to metabolic abnormalities in non-obese populations.
- Evaluation of pathophysiological mechanisms linking normal weight to adverse metabolic profiles.
Main Results:
- Identification of key metabolic derangements (e.g., insulin resistance, dyslipidemia) in non-obese individuals.
- Correlation between specific pathophysiological pathways and increased cardiovascular risk in this cohort.
- Confirmation that normal body weight is an unreliable indicator of metabolic health.
Conclusions:
- Metabolically abnormal normal-weight individuals represent a distinct clinical phenotype at high cardiovascular risk.
- Early identification and targeted interventions are crucial for this population.
- Further research is needed to refine diagnostic criteria and therapeutic approaches.
More Related Videos
06:16White and Brown Adipose Grafts: An Approach to Correct Reproductive, Metabolic, and Renal Deficits in Black and Tan Brachyury (BTBR) Obese Mice
Published on: September 9, 2025
06:08Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:24Metabolic States of the Body: Fasting and Starvation
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
01:18Metabolic States of the Body: The Postabsorptive State
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...